References
- Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
- Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388(10063):3027–3035.
- Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med. 2008;359(3):262–273.
- Crump C, Sundquist K, Sundquist J, et al. Gestational age at birth and mortality in young adulthood. J Am Med Assoc. 2011;306(11):1233–1240.
- Bilsteen JF, Taylor-Robinson D, Børch K, et al. Gestational age and socioeconomic achievements in young adulthood. JAMA Netw Open. 2018;1(8):e186085.
- Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind. Placebo Control Trial. 2020;395:285–293.
- Wójtowicz A, Undas A, Huras H, et al. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett. 2011;32(3):334–339.
- Finneran MM, Gonzalez-Brown VM, Smith DD, et al. Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin. Am J Obstet Gynecol. 2019;220(4):385.e1-385–e6.
- Huang T, Hoffman B, Meschino W, et al. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn. 2010;30(5):471–477.
- Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106(2):260–267.
- Dinglas C, Afsar N, Cochrane E, et al. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease. Am J Obstet Gynecol. 2020;222(5):499.e1-499–e6.
- Yeaton-Massey A, Baer RJ, Rand L, et al. Adverse pregnancy outcomes by degree of maternal serum analyte elevation: a retrospective cohort study. AJP Rep. 2020;10(04):E369–E379.
- Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287–293.e1.
- Boutin A, Gasse C, Guerby P, et al. First-trimester preterm preeclampsia screening in nulliparous women: the great obstetrical syndrome (GOS) study. J Obstet Gynaecol Canada. 2020;43(1):43–49.
- Brosens I, Pijnenborg R, Vercruysse L, et al. The “great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstetr Gynecol. 2011;204:193–201.
- Brosens I, Puttemans P, Benagiano G. Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes. Am J Obstet Gynecol. 2019;221(5):437–456.
- Roberge S, Bujold E, Nicolaides KH. Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am J Obstet Gynecol. 2018;218(5):483–489.
- Van Vliet EOG, Askie LA, Mol BWJ, et al. Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis. Obstetr Gynecol. 2017;129:327–336.
- Duley L, Meher S, Hunter KE, Seidler AL, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659.
- Roberge S, Demers S, Bujold E. Initiation of aspirin in early gestation for the prevention of pre-eclampsia. BJOG. 2013;120(6):773–774.
- Stegmann BJ, Santillan M, Leader B, et al. Changes in antimüllerian hormone levels in early pregnancy are associated with preterm birth. Fertil Steril. 2015;104(2):347–355.e3.
- Kaing A, Jaswa EA, Diamond MP, et al. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction. Fertil Steril. 2020;113(2):444-452.e1.